AMAG Pharmaceuticals Cash from Operations Quarterly:
-9.713M for March 31, 2013AMAG Pharmaceuticals Historical Cash from Operations Quarterly Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | -9.713M |
| Dec. 31, 2012 | 16.81M |
| Sept. 30, 2012 | 3.987M |
| June 30, 2012 | -10.85M |
| March 31, 2012 | -11.11M |
| Dec. 31, 2011 | -21.66M |
| Sept. 30, 2011 | -12.24M |
| June 30, 2011 | -8.678M |
| March 31, 2011 | -21.22M |
| Dec. 31, 2010 | -13.12M |
| Sept. 30, 2010 | -19.87M |
| June 30, 2010 | 43.92M |
| March 31, 2010 | -12.45M |
| Dec. 31, 2009 | -23.30M |
| Sept. 30, 2009 | -24.66M |
| June 30, 2009 | -20.34M |
| March 31, 2009 | -22.42M |
| Dec. 31, 2008 | -21.56M |
| Sept. 30, 2008 | -13.51M |
| June 30, 2008 | -8.737M |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Cash From Operations
An item on a company's cash flow statement. Lists aggregate change in cash position resulting from operations. Includes the company's cash inflows and outflows from the company's core business operations.
Cash from Operations can be thought of as "how much did the firm generate in the day to day operations of the firm?"
Learn More
AMAG Cash from Operations Quarterly Benchmarks
| Companies | |
|---|---|
| BioDelivery Sciences International | -7.463M |
| Repligen Corporation | |
| Shire | 160.40M |
AMAG Cash from Operations Quarterly Rankings
| Overall |
50th percentile 3952 of 8008 |
| Sector |
31st percentile 469 of 685 in Healthcare |
| Industry |
39th percentile 151 of 249 in Biotechnology |
AMAG Cash from Operations Quarterly Range, Past 5 Years
| Minimum | -24.66M | Sep 2009 |
| Maximum | 43.92M | Jun 2010 |
| Average | -10.54M |
AMAG News
AMAG Pharmaceuticals' CEO Discusses Q1 2013 (Results - Earnings Call Transcript
Seeking Alpha Apr 23
Seeking Alpha Apr 23